Literature DB >> 22258927

Genomic analysis uncovers a phenotypically diverse but genetically homogeneous Escherichia coli ST131 clone circulating in unrelated urinary tract infections.

Gemma Clark1, Konrad Paszkiewicz, James Hale, Vivienne Weston, Chrystala Constantinidou, Charles Penn, Mark Achtman, Alan McNally.   

Abstract

OBJECTIVES: To determine variation at the genome level in Escherichia coli ST131 clinical isolates previously shown to be phenotypically diverse.
METHODS: The genomes of 10 ST131 isolates extensively characterized in previous studies were sequenced using combinations of Illumina and 454 sequencing technology. Whole-genome comparisons and phylogenetic comparisons were then performed across the strain set and with other closely related extraintestinal pathogenic E. coli (ExPEC) strain types.
RESULTS: E. coli ST131 is overrepresented in a collection of clinical isolates, and there is large phenotypic variation amongst isolates. In contrast, genome sequencing of a selection of non-related clinical isolates shows almost no genetic variation between ST131 strains, and E. coli ST131 shows evidence of a genetically monomorphic pathogen showing a similar evolutionary trend to hypervirulent Clostridium difficile.
CONCLUSIONS: A dominant circulating clone of E. coli ST131 has been identified in unrelated clinical urine samples in the UK. The clone splits into two distinct subgroups on the basis of antimicrobial resistance levels and carriage of extended-spectrum β-lactamase plasmids. This provides the most comprehensive snapshot to date of the true molecular epidemiology of ST131 clinical isolates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258927     DOI: 10.1093/jac/dkr585

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  30 in total

1.  Prevalent combination of virulence and plasmidic-encoded resistance in ST 131 Escherichia coli strains.

Authors:  Vera Calhau; Graça Ribeiro; Nuno Mendonça; Gabriela Jorge Da Silva
Journal:  Virulence       Date:  2013-10-09       Impact factor: 5.882

Review 2.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Global Extraintestinal Pathogenic Escherichia coli (ExPEC) Lineages.

Authors:  Amee R Manges; Hyun Min Geum; Alice Guo; Thaddeus J Edens; Chad D Fibke; Johann D D Pitout
Journal:  Clin Microbiol Rev       Date:  2019-06-12       Impact factor: 26.132

4.  Whole-genome sequencing of uropathogenic Escherichia coli reveals long evolutionary history of diversity and virulence.

Authors:  Yancy Lo; Lixin Zhang; Betsy Foxman; Sebastian Zöllner
Journal:  Infect Genet Evol       Date:  2015-06-23       Impact factor: 3.342

5.  Genomic and Functional Portrait of a Highly Virulent, CTX-M-15-Producing H30-Rx Subclone of Escherichia coli Sequence Type 131.

Authors:  Amit Ranjan; Sabiha Shaik; Arif Hussain; Nishant Nandanwar; Torsten Semmler; Savita Jadhav; Lothar H Wieler; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

6.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Authors:  Yohei Doi; Yoon Soo Park; Jesabel I Rivera; Jennifer M Adams-Haduch; Ameet Hingwe; Emilia M Sordillo; James S Lewis; Wanita J Howard; Laura E Johnson; Bruce Polsky; James H Jorgensen; Sandra S Richter; Kathleen A Shutt; David L Paterson
Journal:  Clin Infect Dis       Date:  2012-11-13       Impact factor: 9.079

7.  Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage.

Authors:  Arif Hussain; Christa Ewers; Nishant Nandanwar; Sebastian Guenther; Savita Jadhav; Lothar H Wieler; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

8.  Role of homologous recombination in adaptive diversification of extraintestinal Escherichia coli.

Authors:  Sandip Paul; Elena V Linardopoulou; Mariya Billig; Veronika Tchesnokova; Lance B Price; James R Johnson; Sujay Chattopadhyay; Evgeni V Sokurenko
Journal:  J Bacteriol       Date:  2012-11-02       Impact factor: 3.490

9.  Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical sequence type 131 (ST131), clinical non-ST131, and fecal non-ST131 lineages from India.

Authors:  Arif Hussain; Amit Ranjan; Nishant Nandanwar; Anshu Babbar; Savita Jadhav; Niyaz Ahmed
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

10.  Global dissemination of a multidrug resistant Escherichia coli clone.

Authors:  Nicola K Petty; Nouri L Ben Zakour; Mitchell Stanton-Cook; Elizabeth Skippington; Makrina Totsika; Brian M Forde; Minh-Duy Phan; Danilo Gomes Moriel; Kate M Peters; Mark Davies; Benjamin A Rogers; Gordon Dougan; Jesús Rodriguez-Baño; Alvaro Pascual; Johann D D Pitout; Mathew Upton; David L Paterson; Timothy R Walsh; Mark A Schembri; Scott A Beatson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.